Specialists at SSM Health Saint Louis University Hospital are first in the United States to offer a new technology allowing patients to receive 3D breast biopsies in a prone position, a significant benefit for patients in the fight against breast cancer.
Approved by the U.S. Food and Drug Administration in April, the new Affirm™ prone biopsy system was installed at SLU Hospital in August and allows radiologists better access to abnormalities found after mammograms.
“This technology really puts the patient first as it is much faster and more comfortable than older ways of doing biopsies,” says Debbie Bennett, MD, SLUCare breast radiologist and director of breast imaging for SSM Health. “We’re excited to have been chosen as the nation’s first to offer this option to our patients.”
The new biopsy system allows radiologists to biopsy some abnormalities that previously required surgery for diagnosis. The new biopsy system also makes the procedure quicker and more comfortable than other methods.
“This gives us a much better look at abnormalities than previous systems and provides us with faster procedure times for the patient,” says Dr. Bennett.
That feeling was shared by researchers in Europe who were early test sites for the technology. They say physicians are able to visualize more tissue and have access to challenging lesion locations in a faster procedure than traditional breast biopsy.
SLU Hospital was chosen first in the nation by Hologic and offers patients a true multidisciplinary approach to breast cancer with SLUCare radiologists, surgeons, reconstructive surgeons and genetic experts working together to provide specialized care.